Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

20 Jan 2005 07:00

Torex Retail PLC20 January 2005 20th January 2005 Torex Retail plc expands UK Petroleum Business with £2.1m acquisition of Petroleum Services Business Torex Retail plc ("Torex Retail"), the UK's market leader in retail IT systems,today announces the completion of the £2.1m acquisition of Flexiline ForecourtServices Limited ("Flexiline"). Flexiline specialises in the installation andservicing of equipment in petrol filling stations. The £2.1m consideration willbe satisfied by the payment of £1.05m in cash and £1.05m by the issue of1,288,343 new Torex Retail shares. Flexiline, based in Hertfordshire, provides a range of forecourt servicesincluding the project management of service station redevelopment, petrol pumpand system refurbishment, forecourt equipment installation and servicing. Thecompany has grown steadily through winning significant service contracts frommajor retailing groups and achieved sales of £2.5m for the 12 months ended 31stOctober 2004. Flexiline will become part of Torex Retail's expanding Petroleum and ConvenienceDivision and will complement the range of products and services provided for theUK retail petroleum market. Rob Loosemore, Executive Chairman of Torex Retail plc, commented: "The acquisition of Flexiline will add depth to our service offering in theretail petroleum sector. Over the next few years there will be increaseddevelopment and refurbishment activity on forecourts with the introduction ofnew fuels, environmental protection legislation and the addition of outdoorpayment terminals on forecourts. We will now be even better placed to takeadvantage of this increased activity. Flexiline has established an enviable reputation in the market and I expectthat, with the backing of Torex Retail, the company will be in a better positionto win new business from major oil companies. The market is dominated by theservice departments of pump companies and there is no independent company sowell equipped as Flexiline to offer high quality service on the full range ofequipment at filling stations." - ends - Enquiries: Torex Retail plc Citigate Dewe RogersonRob Loosemore, Executive Chairman Seb Hoyle / Ginny PulbrookRichard Thompson, Finance Director Freida MooreTelephone: +44 (0) 870 050 9900 Telephone: +44 (0) 20 7638 9571 Application will be made for the 1,288,343 new shares to be issued pursuant tothe consideration for the acquisition to be admitted to trading on AIM.Admission is expected to become effective on 25 January 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Nov 20249:32 amRNSForm 8.3 - Tissue Regenix Group Plc
12th Nov 20244:05 pmRNSForm 8 (OPD) (Tissue Regenix Group Plc)
12th Nov 20248:46 amRNSForm 8.5 (EPT/NON-RI)
11th Nov 20249:17 amRNSForm 8.5 (EPT/NON-RI)
7th Nov 20249:59 amRNSForm 8.5 (EPT/NON-RI) - Tissue Regenix Group PLC
6th Nov 20241:37 pmRNSForm 8.3 - Tissue Regenix Group PLC
6th Nov 20248:52 amRNSForm 8.5 (EPT/NON-RI)
5th Nov 20242:24 pmRNSForm 8.3 - Tissue Regenix Group PLC
5th Nov 202411:32 amRNSForm 8.5 (EPT/NON-RI)
4th Nov 20244:36 pmRNSResponse to media speculation
10th Sep 20247:00 amRNSInterim results for the six months ended 30 June
18th Jul 20243:52 pmRNSGrant of share options
16th Jul 20247:00 amRNSHalf-Year Trading Update
3rd Jul 20241:16 pmRNSHolding(s) in Company
24th Jun 20244:12 pmRNSHolding(s) in Company
18th Jun 20245:15 pmRNSExercise of Options, Director Dealing and TVR
14th Jun 20247:00 amRNSBuilding purchase
25th Apr 20242:27 pmRNSResult of AGM
10th Apr 20247:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth
5th Apr 20243:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSFinal results for the year ended 31 December 2023
1st Mar 20247:00 amRNSNotice of Results
6th Feb 20247:00 amRNSFirst EU shipment & new distributor agreements
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading update for 2023
23rd Jan 20245:24 pmRNS2023 LTIP Grant
22nd Nov 20234:36 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSHPRA approval & distribution agreement in Spain
18th Sep 202310:40 amEQSHardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
15th Sep 20234:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:01 amRNSNew sports medicine product launch
5th Sep 20237:00 amRNSInterim results
31st Aug 20231:45 pmRNSExercise of Options and Total Voting Rights
21st Aug 20237:00 amRNSNotice of interim results
17th Jul 20237:00 amRNSHalf-Year Trading Update
10th Jul 20237:00 amRNSDistribution agreement for OrthoPure® XT in the UK
25th May 20237:00 amRNSDistribution agreement with Australian Allografts
9th May 202312:00 pmRNSHolding(s) in Company
27th Apr 202312:35 pmRNSResult of AGM, Share Reorganisation &TVR
18th Apr 20237:00 amRNSProposed Share Reorganisation Timetable
5th Apr 20232:55 pmEQSHardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
5th Apr 20237:00 amRNSCEO and CFO Share Purchases
30th Mar 20237:00 amRNSHolding(s) in Company
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
6th Mar 20237:00 amRNSNotice of results and Investor presentation
31st Jan 20237:01 amRNSTrading update for 2022
31st Jan 20237:00 amRNSChange of Adviser
18th Jan 202310:06 amRNSHolding(s) in Company
18th Jan 20237:00 amRNSChinese distribution agreement for OrthoPure® XT
7th Dec 20227:00 amRNSProduct launch in dCELL® division

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.